Frecuencia de asociación del factor reumatoide en pacientes con cáncer de mama
Del Rivero Hernández, Leonel G; Silva Juan, Alejandro; Martínez Cairo-Cueto, Salvador.
Alergia (Méx.)
; 47(1): 17-21, ene.-feb. 2000. tab
Artículo en Español | LILACS | ID: lil-280366
Documentos relacionados
Rheumatoid Factors in Hepatitis B and C Infections: Connecting Viruses, Autoimmunity, and Cancer.
CTLA-4 blockade drives loss of T<sub>reg</sub> stability in glycolysis-low tumours.
Direct Tumor Killing and Immunotherapy through Anti-SerpinB9 Therapy.
Tissue-resident FOLR2<sup>+</sup> macrophages associate with CD8<sup>+</sup> T cell infiltration in human breast cancer.
Phase I/II clinical trial of a Wilms' tumor 1-targeted dendritic cell vaccination-based immunotherapy in patients with advanced cancer.
[Cardio-oncology and cardio-obstetrics : crucial role of a multidisciplinary approach].
CD56+ immune cell infiltration and MICA are decreased in breast lobules with fibrocystic changes.
Immune State Conversion of the Mesenteric Lymph Node in a Mouse Breast Cancer Model.
YTHDF1's Regulatory Involvement in Breast Cancer Prognosis, Immunity, and the ceRNA Network.
Bone marrow microenvironment in cancer patients: immunological aspects and clinical implications.